Multitarget Combination Immunosuppressive Therapy for Primary Membranous Nephropathy

Am J Kidney Dis. 2021 Dec;78(6):774-776. doi: 10.1053/j.ajkd.2021.06.012. Epub 2021 Aug 28.

Authors

Najia Idrees¹, Laurence H Beck Jr²

Affiliations

¹ Section of Nephrology, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts.
² Section of Nephrology, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts. Electronic address: Laurence.Beck@bmc.org.

PMID: 34465505
DOI: 10.1053/j.ajkd.2021.06.012

No abstract available

Publication types

Editorial
Comment

MeSH terms

Glomerulonephritis, Membranous* / diagnosis
Glomerulonephritis, Membranous* / drug therapy
Humans
Immunosuppression Therapy
Immunosuppressive Agents

Substances

Immunosuppressive Agents